 |
|
Sales & Support
Request A Quote - Email
Select Language
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Product Name: | Tirzepatide | Other Name: | LY3298176, GIP/GLP-1 RA |
|---|---|---|---|
| Package: | 5mg, 10mg, 15mg, 30mg/vial, 10 Vials/ Kit | CAS: | 2023788-19-2 |
| Color: | White Lyophilized Powder | MW: | 4813.45 |
| Grade: | Phamaceutical Grade | MOQ: | 1 Box |
Manufacturer Supply Peptide Tirzepatide GIP/GLP-1 RA Tirzepatide Powder 5mg 10mg Vials
Product desciption:
Tirzepatide was approved for medical use in the United States in May 2022, in the European Union in September 2022, in Canada in November 2022, and in Australia in December 2022. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. It was approved by the FDA for weight loss in November 2023, under the brand name Zepbound. In November 2023, the UK Medicines and Healthcare products Regulatory Agency revised the indication for tirzepatide to include treatment for weight loss.
Related products:
| GH 10iu 191AA | GH Fragment 176-191 | Adipotide |
| Melanotan II | Tirzepatide | Epithalon |
| Getropin | Jintrop | Oxytocin 2 |
| Hygetrop | PT-141 | |
| HCG 5000iu Livzlon brand | Taitropin | GHK-CU |
| HCG 5000iu | BPC-157 | Fox04 dri |
| TB-500 | CJC-1295 | DSIP |
| Hexarelin | HMG 75iu | AOD9604 |
| Ipamorelin | Sermorelin | MGF |
| Selank | Semaglutide | Peg-mgf |
| Semax | Tesamorelin | EPO 3000iu |
| Thymalin | Thymosin alpha | Follistatin 344 |
| GHRP2 | GHRP6 | Kisspeptin-10 Peptide |
| Gondorelin | IGF-1 DES | Dermorphin |
| IGF-LR3 | Melanotan | ACE-031 |
| Mots-C | Myostatin | AICAR |
| Please contact us for more products | ||
Product Photos:
Certifications:
Company:
FAQ:
Contact Person: jason
Tel: +86 17792557883
